Kendra Rasmussen
Psychiatric/Mental Health · Springfield, MONPI 1619358306
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.0% of the total across 222 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 22.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,644, 7.6 times the $348 reported in 2021. Among psychiatric/mental health clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 222 payments — averaging $26.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$1K
- Johnson & Johnson$759
- Axsome Therapeutics, Inc.$724
- E.r. Squibb & Sons, L.L.C.$539
- AbbVie$469
- Alkermes, Inc.$377
- plus $2K from 12 others
What the payments were for
- Food & beverage$5,76598%
- Education$1202%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 57 | $1,303 |
| Johnson & Johnson | 15 | $759 |
| Axsome Therapeutics, Inc. | 30 | $724 |
| E.r. Squibb & Sons, L.L.C. | 20 | $539 |
| AbbVie | 21 | $469 |
| Alkermes, Inc. | 14 | $377 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 17 | $361 |
| Neurocrine Biosciences, Inc. | 8 | $319 |
| Teva Pharmaceuticals USA, Inc. | 8 | $204 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $185 |
| Vanda Pharmaceuticals Inc. | 6 | $160 |
| Supernus Pharmaceuticals, Inc. | 2 | $156 |
| Lundbeck LLC | 6 | $133 |
| AstraZeneca | 1 | $107 |
| Indivior Inc. | 2 | $30 |
| Radius Health, Inc. | 1 | $25 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$485
- LYBALVI$401
- Auvelity$373
- ABILIFY MAINTENA$373
- ABILIFY ASIMTUFII$248
- REXULTI$247
- INGREZZA$140
- COBENFY$135
- QELBREE$127
- VRAYLAR$125
- INVEGA SUSTENNA$106
How this compares
$5,884 in reported general payments places this provider in the 90th percentile of 565 psychiatric/mental health providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 29 | $42,690 |
| AuvelityDextromethorphan Hbr/Bupropion | 17 | $21,525 |
| VraylarCariprazine Hcl | 13 | $19,171 |
| TrintellixVortioxetine Hydrobromide | 16 | $7,736 |
| Aripiprazole | 31 | $1,566 |
| Haloperidol | 18 | $866 |
| Duloxetine Hcl | 30 | $499 |
| Buspirone Hcl | 39 | $495 |
| Trazodone Hcl | 46 | $433 |
| Naltrexone Hcl | 15 | $418 |
| Propranolol Hcl | 20 | $302 |
| Lamotrigine | 22 | $268 |
| Clonidine Hcl | 30 | $245 |
| Prazosin Hcl | 21 | $234 |
| Amitriptyline Hcl | 30 | $221 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti | $1,303 | $42,69029 claims |
| Axsome Therapeutics, Inc.Auvelity | $724 | $21,52517 claims |
| AbbVieVraylar | $469 | $19,17113 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $185 | $7,73616 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 565 psychiatric/mental health providers in Missouri.
Other psychiatric/mental health in Springfield
- Erin DuvallSpringfield$275K
- Emily WoukSpringfield$90K
- Karin BaughmanSpringfield$16K
- Tedra EstisSpringfield$13K
- Brian SmithSpringfield$10K
- Ashlee RossnerSpringfield$8K
- Holly JulianSpringfield$6K
- Aldijana SacicSaint Louis$510K
- Laurel OwensLees Summit$246K
- Julie WaterburySaint Louis$135K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.